Bristol-Myers Squibb reported $2.04 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 1.60 1.63 Oct/29
FY2026Q2 Jun/2026 2.04 1.61 1.46 Jul/30
FY2026Q1 Mar/2026 1.58 1.45 1.80 Apr/30
FY2025Q4 Dec/2025 1.26 1.61 1.67 Feb/05
FY2025Q3 Sep/2025 1.63 1.69 1.80 Oct/30




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Abbott USD 1.31 0.16 Jun/2026
ALKERMES USD 0 0.4 Jun/2026
Amgen USD 5.15 0.14 Mar/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Drreddys Laboratories INR 0.06 0.1 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Medtronic USD 1.55 0.19 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Novartis USD 2.41 0.42 Jun/2026
Novo Nordisk DKK 10.91 4.87 Mar/2026
Perrigo USD 0.43 0.34 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 1.23 0.09 Mar/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 2.09 0.21 Jun/2026
Sanofi EUR 2.17 2.84 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Zoetis USD 1.53 0.05 Mar/2026